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Introduction. Classically, pulmonary tuberculosis (PT) was a contraindication for radiotherapy (RT) in lung cancer patients (LCP),
because the provoked local immunosuppression could reactivate the infection. The study of Zack et al. in 1974 found that the
surviving fraction of mycobacterium strains irradiated mutate into tuberculostatic drug resistance. However, in 2010, Helal et al.
published that; after irradiating mycobacterium strains in vitro some multiresistant strains became sensible and a change in the
expression of multiple genes in microbes irradiated was produced. These results are contradictory.
Objective. To assess the effects of irradiation on microbiological characteristics of multiresistant mycobacterium strains. Here we
present our preliminary results.
Material and methods. We studied 5 multiresistant M. tuberculosis complex strains, identiﬁed by Gen Probe Accuprobe. Liquid
antibiotic sensitivity study to isoniazid, rifampicin, ethambutol, streptomycin and pyrazinamide was performed by BD Bactec
MGIT 960 system as recommended by the manufacturer. The study was performed twice, before and after strain irradiation with
one fraction of 24Gy, 6MV LINAC photons.
Results. One of the ﬁve strains irradiated showed a phenotypic change to sensitivity to streptomycin after irradiation.
Conclusions. If the effect of variation to sensitivity is conﬁrmed, this study raises 2 interesting applications of public health
impact: First, in multidrug-resistant PT patients, in vitro test might be performed prior to treatment, and selected for a very
low dose irradiation to obtain mutations to sensitivity to drugs used in the treatment and eliminate resistance. Secondly, in LCP
with PT to be treated by RT, the in vitro test before RT would allow choose appropriate antibiotics to every patient. These two
potential applications have motivated that we are currently carrying out the irradiation of a larger number of strains to verify
the consistency and reproducibility of the preliminary results obtained.
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Objective. Locally advanced rectal cancer (LARC) treated with preoperative radio-chemotherapy (RT-CT) produces a wide range
of disease control rates, and mechanisms of tumor resistance are not fully understood. Our goal is to investigate the prognostic
value of the expression of -catenin and E-cadherin at the time of diagnosis and after RT-CT, to ascertain whether RT-CT induces
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